These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers. McVernon J, Nolan T, Richmond P, Reynolds G, Nissen M, Lambert SB, Marshall H, Papa T, Rehm C. Pediatr Infect Dis J; 2012 Jan; 31(1):e15-23. PubMed ID: 22094636 [Abstract] [Full Text] [Related]
7. Meningococcal quadrivalent (serogroups A, C, w135, and y) conjugate vaccine (Menveo): in adolescents and adults. Deeks ED. BioDrugs; 2010 Oct 01; 24(5):287-97. PubMed ID: 20795751 [Abstract] [Full Text] [Related]
9. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine. Robertson CA, Greenberg DP, Hedrick J, Pichichero M, Decker MD, Saunders M. Vaccine; 2016 Oct 17; 34(44):5273-5278. PubMed ID: 27642132 [Abstract] [Full Text] [Related]
13. MenACWY-TT vaccine for active immunization against invasive meningococcal disease. Papaevangelou V, Spyridis N. Expert Rev Vaccines; 2012 May 17; 11(5):523-37. PubMed ID: 22827239 [Abstract] [Full Text] [Related]
14. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old. Hu JL, Tao H, Li JX, Dai WM, Song B, Sun JF, Liu P, Tang J, Liu WY, Wang SY, Zhu FC. Hum Vaccin Immunother; 2015 May 17; 11(5):1120-8. PubMed ID: 25833163 [Abstract] [Full Text] [Related]